U.S. pharma large copyright scrapped two experimental weight loss pills final 12 months—a as soon as-every day capsule, lotiglipron, on account of elevated liver enzymes in addition to a 2 times-day by day pill, danuglipron, due to sturdy Negative effects—but CEO Albert Bourla has reported the company is set to “Participate in and win” whil